The Innovation Life > 2023 Vol. 1 > No. 3 > 100032
Next Article Previous Article
COMMENTARY   Open Access     Cite

Decoding the Pan-Cancer regulatory landscape: Insights from proteogenomics and post-translational modifications

  • 1.

    Clinical Proteomics Research Center, Massachusetts General Hospital, Harvard Medical School, Boston 02155, USA

  • 2.

    Department of Pathology, Albert Einstein College of Medicine, Bronx 10461, USA

  • 3.

    Einstein Pathology Single-cell & Bioinformatics laboratory, Bronx 10461, USA

More Information
The Innovation Life  1(3),  https://doi.org/10.59717/j.xinn-life.2023.100032  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Mani, D.R., Krug, K., Zhang, B., et al. (2022). Cancer proteogenomics: Current impact and future prospects. Nat. Rev. Cancer 22 : 298−313. DOI: 10.1038/s41568-022-00446-5.

    View in Article Google Scholar

    [2] Rodriguez, H., Zenklusen, J.C., Staudt, L.M., et al. (2021). The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment. Cell 184 : 1661−1670. DOI: 10.1016/j.cell.2021.02.055.

    View in Article Google Scholar

    [3] Li, Y., Porta-Pardo, E., Tokheim, C., et al. (2023). Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell 186 : 3921-394410. DOI: 10.1016/j.cell.2023.07.014.

    View in Article Google Scholar

    [4] Geffen, Y., Anand, S., Akiyama, Y., et al. (2023). Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186 : 3945-3967. DOI: 10.1016/j.cell.2023.07.013.

    View in Article Google Scholar

    [5] Li, Y., Dou, Y., Da Veiga Leprevost, F., et al. (2023). Proteogenomic data and resources for pan-cancer analysis. Cancer Cell 41 : 1397−1406. DOI: 10.1016/j.ccell.2023.06.009.

    View in Article Google Scholar

    • CITED BY

  • Cite this article:

    Deng W. and Yin S. (2023). Decoding the Pan-Cancer regulatory landscape: Insights from proteogenomics and post-translational modifications. The Innovation Life 1(3), 100032. https://doi.org/10.59717/j.xinn-life.2023.100032
    Deng W. and Yin S. (2023). Decoding the Pan-Cancer regulatory landscape: Insights from proteogenomics and post-translational modifications. The Innovation Life 1(3), 100032. https://doi.org/10.59717/j.xinn-life.2023.100032

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(2701) PDF downloads(1082) Cited by(0)

Relative Articles

Article Contents
ABOUT THIS ARTICLE

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    Journal links

    {{newsColumn.name}}

    Stay connected

    Copyright © Innovation Press